Mentored Clinical Scientist Development Award (Parent K08)(Postdoctoral Individuals/New Independent Researchers)
This award enables candidates holding professional degrees (e.g.,
M.D., D.O., D.V.M., or equivalent degrees) to undertake 3 to
5 years of special study and supervised research with the goal
of becoming independent investigators. The award also allows
awardees to pursue a research career development program suited
to their experience and capabilities under a mentor who is competent
to provide guidance in the chosen research area.
Institutions may submit applications on behalf of candidates
who hold professional degrees. At least 2 years must have
elapsed since the health professional degree was granted.
Candidates can have varying levels of clinical training and
All candidates must be U.S. citizens, noncitizen nationals,
or legal permanent residents of the U.S. Persons with temporary
or student visas are not eligible. The grantee institution
must have a strong, well-established research and research
training program in the chosen area, accomplished faculty
in the basic and clinical sciences, and a commitment to the
candidate's research development. The proposed program should
include an appropriate mentor.
NHLBI requires an IRB-approved data and safety monitoring plan for: (1) all clinical trials regardless of phase, and (2) all clinical research with greater than minimal risk.
Mentored Clinical Scientist Development Award (K08)
Program Announcement (PA-11-193)
The NHLBI Web site also lists training programs under the
category Request for Applications/Proposals
& Program Announcements through the application receipt
Leave Guidelines for Recipients of Mentored Career Award
Reduction in Percent Effort for NHLBI Mentored Career Development K Awards (NOT-HL-06-118)
NHLBI's Division of Blood Diseases and Resources (DBDR) Program Description
NHLBI's Division of Cardiovascular Sciences (DCVS) Program Description
NHLBI's Division of Lung Diseases (DLD) Program Description
Who is eligible? Candidates must have a health professional
doctoral degree, such as the M.D., D.O., D.V.M., or equivalent
degree, and a professional license to practice in the United
States. Documentation of active licensure should be included
in the application.
NHLBI has a 6 year limit of cumulative support on institutional and mentored Ks (e.g., K12 or KL2 plus the K08). A candidate
for the K08 may not concurrently apply for or have an award
pending for any other NIH career development award.
The opportunities? Research training/Career development
Duration of support? 3 to 5 years, at least 9 person-months (75 percent
of full-time professional effort) to conducting patient-oriented research and related career development activities.
Where? At an institution with the staff and facilities
needed for the proposed research
Applications due? February 12, June 12, and October
12 - new applications;
March 12, July 12, and November 12 - resubmission applications.
Salary: Up to $75,000 per year plus fringe benefits
and up to $25,000 per year for research support for new awards.
The actual salary must be consistent with the salary structure
of the grantee institution and the level of effort.
Advisory Committee: NHLBI strongly encourages K08 candidates to include an Advisory Committee composed of the candidate's mentor(s) and two or three other senior faculty members. If the candidate does not propose an Advisory Committee, she/he should document which individuals are available to cover all areas of expertise that are required for the research plan and career development.
Concurrent Competing Applications: K08 applicants may not hold any other Federal or non-Federal equivalent salary award, such as the American Heart Association Scientist Development Grant. NHLBI suggests that K08 applications include biographical sketches of the collaborators and consultants.
Please note: Candidates should submit an application for the "Mentored Research Scientist Development Award" (Parent K01, PA-11-190) if they are interested in the following focused research areas:
--Highly innovative epidemiological research that elucidates the mechanisms, etiology, pathogenesis, prevention, diagnosis and treatment of heart, lung, blood diseases, and sleep disorders.
--Biostatistics research leading to the development of new methods for designing and analyzing clinical studies, including clinical trials, epidemiologic and genetics studies in heart, lung, blood diseases, and sleep disorders.
--Comparative effectiveness research that involves the comparison of screening, diagnostic, preventive or treatment strategies of heart, lung, blood diseases, and sleep disorders using appropriate methods from randomized controlled trials to the analysis of electronic medical records.
How to apply: Applications submitted in response to
this Funding Opportunity Announcement (FOA) for Federal assistance
must be submitted electronically through Grants.gov
using the SF 424 Research and Related (R&R) forms and
the SF 424 (R&R) Application Guide.
The SF 424 (R&R) Application Guide for NIH and Other PHS Agencies includes Part 1.7 Supplemental Instructions to the SF 424 (R&R) for Preparing an Individual Research Career Development Award (CDA) Application ("K" series).
Page Limitations: All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed.
Letters of Reference: Candidates must carefully follow the SF424 (R&R) Application Guide, including the time period for when letters of reference will be accepted. Applications lacking the required reference letters will not be reviewed (see: NOT-OD-11-079). Please note that the specified format must be used. This is a separate process from submitting an application electronically. Reference letters are submitted directly through the eRA Commons Referee Information link and not through Grants.gov
For more information on specific program opportunities,
Drew Carlson, Ph.D.
Division of Cardiovascular Science, NHLBI
Rockledge II Building, Room 8142
6701 Rockledge Drive, MSC 7940
Bethesda, MD 20892-7940
Telephone: (301) 435-0535
FAX: (301) 480-7404
Last Updated: July 2011